Protocol for the ProCare Trial: A phase II randomised controlled trial of shared care for follow-up of men with prostate cancer

BMJ Open

Volumn 4, Issue 3, 2014, Pages

  Emery, Jon ^a,b   Doorey, Juanita ^b   Jefford, Michael ^c   King, Madeleine ^d   Pirotta, Marie ^a   Hayne, Dickon ^b,e   Martin, Andrew ^f   Trevena, Lyndal ^g   Lim, Tee ^h   Constable, Roger ⁱ   Hawks, Cynthia ^e   Hyatt, Amelia ^c   Hamid, Akhlil ^h   Violet, John ^c   Gill, Suki ^c   Frydenberg, Mark ^j   Schofield, Penelope ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e FREMANTLE HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h ROYAL PERTH HOSPITAL   (Australia)

ⁱ Cancer Found of Western Australia   (Australia)

^j MONASH UNIVERSITY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVOR; CLINICAL PROTOCOL; DEPRESSION; DISTRESS SYNDROME; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; MALE; PATIENT CARE; PATIENT INFORMATION; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PROSTATE CANCER; QUALITY OF LIFE; SCREENING; AUSTRALIA; CHECKLIST; CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; INTERDISCIPLINARY COMMUNICATION; METHODOLOGY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PATIENT PARTICIPATION; PHASE 2 CLINICAL TRIAL; PHYSICIAN ATTITUDE; PROSTATIC NEOPLASMS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANXIETY; AUSTRALIA; CHECKLIST; CLINICAL PROTOCOLS; COST OF ILLNESS; DEPRESSION; FOLLOW-UP STUDIES; GENERAL PRACTITIONERS; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; PATIENT CARE TEAM; PATIENT PARTICIPATION; PHYSICIAN'S ROLE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 84897520795     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-004972     Document Type: Article

References (61)

1. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079-92.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
3. Cancer in Australia: an overview. Canberra: Australian Institute of Health and Welfare, 2012.
4. Cancer incidence projections: Australia, 2011-2020. Canberra: Australian Institute of Health and Welfare, 2012.
5. Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009;27:2758-65.
6. SEER Stat Fact Sheets: Prostate Cancer: National Cancer Institute, 2013.
7. O'Brien R, Rose PW, Campbell C, et al. Experiences of follow-up after treatment in patients with prostate cancer: a qualitative study. BJU Int 2010;106:998-1003.
8. Boberg E, Gustafson D, Hawkins R, et al. Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns 2003;49:233-42. (Pubitemid 36294236)
9. Ream E, Quennell A, Fincham L, et al. Supportive care needs of men living with prostate cancer in England: a survey. Br J Cancer 2008;98:1903-9. (Pubitemid 351821569)
10. Resnick MJ, Koyama T, Fan K-H, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013;368:436-45.
11. Cockle-Hearne J, Charnay-Sonnek F, Denis L, et al. The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries. Br J Cancer 2013;109:2121-30.
12. Smith DP, Supramaniam R, King MT, et al. Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol 2007;25:2560-6. (Pubitemid 47041229)
13. Smith DP, King MT, Egger S, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ 2009;339:b4817.
14. Khan NF, Watson E, Rose PW. Primary care consultation behaviours of long-term, adult survivors of cancer in the UK. Br J Gen Pract 2011;61:197-9.
15. Heins MJ, Korevaar JC, Rijken PM, et al. For which health problems do cancer survivors visit their General Practitioner? Eur J Cancer 2013;49:211-18.
16. Role Redesign Primary Care - Shared Care. Models of Cancer Treatment and Surveillance Post Treatment. Final Report. . In: Communications. GCa, editor. Canberra: Cancer Australia, 2010.
17. Pascoe SW, Neal RD, Allgar VL, et al. Psychosocial care for cancer patients in primary care? Recognition of opportunities for cancer care. Fam Pract 2004;21:437-42. (Pubitemid 39162013)
18. Richards M, Corner J, Maher J. The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors. Br J Cancer 2011;105(Suppl 1):S1-4.
19. Guideline development group. Prostate cancer: diagnosis and treatment. London: National Institute of Clinical Excellence, 2008.
20. Lewis RA, Neal RD, Williams NH, et al . Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract 2009;59:e234-47.
21. Murchie P, Nicolson MC, Hannaford PC, et al. Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial. Br J Cancer 2010;102:1447-55.
22. Emery JD, Trevena L, Mazza D, et al. The role of primary and community-based healthcare professionals in early detection and follow-up of cancer: a rapid review of best practice models. Sydney, NSW: Sax Institute, 2013.
23. Emery JD, Shaw K, Williams B, et al. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol 2014;11:38-48.
24. Taggart F, Donnelly P, Dunn J. Options for early breast cancer follow-up in primary and secondary care - a systematic review. BMC Cancer 2012;12:238.
25. Gunn JM, Palmer VJ, Naccarella L, et al. The promise and pitfalls of generalism in achieving the Alma-Ata vision of health for all. Med J Aust 2008;189:110-12.
26. Grunfeld E, Earle C. The Interface Between Primary and Oncology Speciality Care: Treatment Through Survivorship. J Natl Cancer Inst Monogr 2010;2010:25-30.
27. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC, 2006.
28. Hodgkinson K, Butow P, Hobbs KM, et al. After cancer: the unmet supportive care needs of survivors and their partners. J Psychosoc Oncol 2007;25:89-104. (Pubitemid 350166025)
29. McIntosh HM, Neal RD, Rose P, et al. Follow-up care for men with prostate cancer and the role of primary care: a systematic review of international guidelines. Br J Cancer 2009;100:1852-60.
30. Jiwa M, Saunders CM, Thompson SC, et al. Timely cancer diagnosis and management as a chronic condition: opportunities for primary care. Med J Aust 2008;189:78-82.
31. Walsh J, Harrison JD, Young JM, et al. What are the current barriers to effective cancer care coordination? A qualitative study. BMC Health Serv Res 2010;10:132.
32. Chen Y, Brennan N, Magrabi F. Is email an effective method for hospital discharge communication? A randomized controlled trial to examine delivery of computer-generated discharge summaries by email, fax, post and patient hand delivery. Int J Med Inform 2010;79:167-72
33. Jefford M, Baravelli C, Dudgeon P, et al. Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol 2008;26:2272-7.
34. Grunfeld E, Julian J, Pond G, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 2011;29:4755-62.
35. Jefford M, Schofield P, Emery J. Improving survivorship care. J Clin Oncol 2012;30:1391-2.
36. Brown RF, Butow PN, Sharrock MA, et al. Education and role modelling for clinical decisions with female cancer patients. Health Expect 2004;7:303-16. (Pubitemid 39576285)
37. Barlow J, Wright C, Sheasby J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 2002;48:177-87. (Pubitemid 36158880)
38. Deadman J, Leinster S, Owens R. Taking responsibility for cancer treatment. Soc Sci Med 2001;53:669-77. (Pubitemid 32611686)
39. Cockle-Hearne J, Faithfull S. Self-management for men surviving prostate cancer: a review of behavioural and psychosocial interventions to understand what strategies can work, for whom and in what circumstances. Psychooncology 2010;19:909-22.
40. Griffin SJ, Kinmonth AL, Veltman MW, et al. Effect on health-related outcomes of interventions to alter the interaction between patients and practitioners: a systematic review of trials. Ann Fam Med 2004;2:595-608. (Pubitemid 39643435)
41. Dimoska A, Tattersall MH, Butow PN, et al. Can a 'prompt list' empower cancer patients to ask relevant questions? Cancer 2008;113:225-37.
42. Jefford M, Karahalios A, Angle A. Understanding issues for cancer survivors: informing the development of a written information booklet. Psychooncology 2007;16:S273.
43. Ryan P, Lauver DR. The efficacy of tailored interventions. J Nurs Scholarsh 2002;34:331-7. (Pubitemid 41743567)
44. Demark-Wahnefried W, Clipp EC, Lipkus IM, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol 2007;25:2709-18. (Pubitemid 47123178)
45. Developing and evaluating complex interventions: new guidance. London: Medical Research Council, 2008.
46. Campbell N, Murray E, Darbyshire J, et al. Designing and evaluating complex interventions to improve healthcare. BMJ 2007;334:455-9. (Pubitemid 46586602)
47. Jacobsen P, Donovan K, Trask P. Screening for psychologic distress in ambulatory care patients. Cancer 2005;103:1494-502.
48. Localised prostate cancer: a guide for men and their families. Andrology Australia & Australian Prostate Cancer Collaboration, 2009.
49. Heidenreich A, Bolla M, Joniau S, et al. Guidelines on prostate cancer. European Association of Urology, 2009.
50. Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff 2001;20:64-78. (Pubitemid 33707442)
51. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
52. Bjellanda I, Dahlb A, Haugc T, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
53. Luckett T, Butow PN, King MT, et al. A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 2010;18:1241-62.
54. Hodgkinson K, Butow P, Hunt GE, et al. The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure). Psychooncology 2007;16:796-804. (Pubitemid 47456238)
55. Schofield P, Gough K, Lotfi-Jam K, et al. Validation of the Supportive Care Needs Survey - short form 34 with a simplified response format in men with prostate cancer. Psychooncology 2012;21:1107-12.
56. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
57. Marshall G, Hays R. The patient satisfaction questionnaire short-form (PSQ-18) . RAND Corporation, 1994.
58. Ware JE Jr, Davies-Avery A, Stewart AL. The measurement and meaning of patient satisfaction. Health Med Care Serv Rev 1978;1:1, 3-15.
59. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-92.
60. D'Amico AV. Combined-modality staging for localized adenocarcinoma of the prostate. Oncology 2001;15:1049 -59; discussion 60-2, 64-5, 69-70, 73-5.
61. Watson EK, Rose P, Neal RD, et al. Personalised cancer follow-up: risk stratification, needs assessment or both? Br J Cancer 2012;106:1-5.